National Multiple Sclerosis Society

SRM (Strategic Resource Management) Welcomes Former Director of Payments at NatWest Marion King to International Advisory Board

Retrieved on: 
Thursday, September 8, 2022

SRM (Strategic Resource Management), an independent advisory firm serving financial institutions and other industries across North America and Europe, today announces that Marion King has joined its International Advisory Board.

Key Points: 
  • SRM (Strategic Resource Management), an independent advisory firm serving financial institutions and other industries across North America and Europe, today announces that Marion King has joined its International Advisory Board.
  • Most recently, King was responsible for delivering payments strategy and overseeing payments architecture, operations, and innovation at NatWest Group, a leading financial institution in the UK.
  • In addition to her new role with the SRM International Advisory Board, King serves as chair of the advisory board of the Payments Association.
  • Im delighted to join the advisory board at SRM, said King.

Capital Square Founder and Chief Executive Officer Honored by National Multiple Sclerosis Society's Virginia--West Virginia Chapter

Retrieved on: 
Wednesday, September 7, 2022

Rogers will be presented with the award at the National Multiple Sclerosis Society's Annual Richmond Dinner of Champions on September 27, 2022.

Key Points: 
  • Rogers will be presented with the award at the National Multiple Sclerosis Society's Annual Richmond Dinner of Champions on September 27, 2022.
  • The award is the most prestigious honor bestowed by the National MS Society at the chapter level.
  • It recognizes Rogers' exceptional leadership and outstanding commitment to the local community, including those whose lives have been affected by the unpredictable challenges of multiple sclerosis.
  • Additionally, Capital Square was listed by Virginia Business on their "Best Places to Work in Virginia" report in 2019 and their "Fantastic 50" reports in 2019 and 2020.

Accelerated Cure Project, Quest Diagnostics and the National Multiple Sclerosis Society Form Research Collaboration to Evaluate COVID-19 Vaccine Efficacy in Patients with Multiple Sclerosis

Retrieved on: 
Thursday, September 1, 2022

WALTHAM, Mass., Sept. 1, 2022 /PRNewswire/ -- Accelerated Cure Project (ACP, www.acceleratedcure.org) for multiple sclerosis (MS), with its iConquerMS™ People-Powered Research Network (www.iConquerMS.org) initiative, is collaborating with Quest Diagnostics and the National Multiple Sclerosis Society (www.nationalMSsociety.org) to study immune response to COVID-19 vaccinations of people living with multiple sclerosis (MS).

Key Points: 
  • "We have had a long and productive collaboration with Accelerated Cure Project and its iConquerMS network and we're looking forward to working with them and with Quest Diagnostics on this important project."
  • This research project is a sub-study of the larger COVID-19 VaccinE Response in MS Project (COVER-MS Project).
  • Quest Diagnostics will provide several services to support the research initiative, including SARS-CoV-2 serological IgG antibody and T-Cell testing to determine COVID-19 immune response in the study participants.
  • The major programs of Accelerated Cure Project are the ACP Repository, the iConquerMS People-Powered Research Network and the MS Minority Research Engagement Partnership Network.

Devic's Syndrome Treatment Global Market Report 2022: Soliris (Eculizumab) to Fuel Considerable Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, August 8, 2022

The key factors responsible for growth of global Devic's syndrome treatment market are rising awareness & prevalence related to orphan diseases, recent launch of first-target specific drug Soliris (Eculizumab) and strong drug pipeline expected to provide significant growth in the market.

Key Points: 
  • The key factors responsible for growth of global Devic's syndrome treatment market are rising awareness & prevalence related to orphan diseases, recent launch of first-target specific drug Soliris (Eculizumab) and strong drug pipeline expected to provide significant growth in the market.
  • This report comprises in-depth information related to the Devic's Syndrome treatment market along with major factors affecting or assisting market such as opportunities, drivers, & restraints.
  • This report covered detailed info related to the global Devic's syndrome treatment market segmented based on drug type, and geography.
  • Global Devic's Syndrome Treatment (DST) Market: Market Dynamics and Future Outlook
    Chapter 4.

DonorDrive Named Salesforce.org's 2022 Nonprofit Product Partner of the Year

Retrieved on: 
Monday, July 25, 2022

DonorDrive , an EngageSmart ( NYSE: ESMT ) solution and makers of an advanced enterprise digital fundraising platform, announced it has been named Salesforce.orgs 2022 Nonprofit Product Partner of the Year for the Americas.

Key Points: 
  • DonorDrive , an EngageSmart ( NYSE: ESMT ) solution and makers of an advanced enterprise digital fundraising platform, announced it has been named Salesforce.orgs 2022 Nonprofit Product Partner of the Year for the Americas.
  • The award was presented during the Salesforce.org Unite Partner Summit on June 1, 2022.
  • Salesforce.org is thrilled to award DonorDrive the 2022 Product Partner of the Year award for its success in the nonprofit sector, said David Averill, Vice President of AMER Alliances and Channels at Salesforce.org.
  • DonorDrive has been a highly-valued partner to Salesforce.org and proven its ability to help nonprofits reach their goals and drive greater impact for their causes.

FRB Forms Elder Law Practice Group Led by Penny B. Kassel, Esq.

Retrieved on: 
Tuesday, July 19, 2022

For more than 35 years Ms. Kassel has devoted the majority of her time to elder law matters, estate planning, and estate administration matters.

Key Points: 
  • For more than 35 years Ms. Kassel has devoted the majority of her time to elder law matters, estate planning, and estate administration matters.
  • Her elder law practice provides clients with comprehensive representation for their legal needs during some of life's biggest challenges.
  • "I'm extraordinarily proud to bring Penny into the firm to lead our new Elder Law practice group," FRB Managing Partner Kenneth Falcon said.
  • She is also a past director of the Nassau County Bar Association and former chair of its Elder Law Committee.

ChenMed Repeats as Healthiest Employer Honoree

Retrieved on: 
Wednesday, June 22, 2022

MIAMI, June 22, 2022 /PRNewswire/ -- ChenMed, a leading senior-focused primary care practice operating nearly 100 centers in 12 states, is one of 24 companies and organizations recognized by the South Florida Business Journal as 2022 Healthiest Employers. ChenMed is the only healthcare company honored on the new list of South Florida employers "that have continued to keep their employees' well-being top of mind during the challenges of the last year." ChenMed also was recognized in the publication's 2021 Healthiest Employers list.

Key Points: 
  • ChenMed also was recognized in the publication's 2021 Healthiest Employers list.
  • "At ChenMed, wellness isn't only about great perks and amazing benefits.
  • ChenMed also supports other experiences such as Bike MS ride and Mercedes Benz Corporate Run based on team member suggestions and interests.
  • ChenMed brands include Chen Senior Medical Center , Dedicated Senior Medical Center and JenCare Senior Medical Center.

THE HOWARD HUGHES CORPORATION® ANNOUNCES APPOINTMENT OF LINDA FOGGIE TO BOARD OF DIRECTORS

Retrieved on: 
Wednesday, June 8, 2022

HOUSTON, June 8, 2022 /PRNewswire/ -- The Howard Hughes Corporation (NYSE: HHC) announced today the appointment of Linda Foggie to its Board of Directors, effective June 8, 2022.

Key Points: 
  • HOUSTON, June 8, 2022 /PRNewswire/ -- The Howard Hughes Corporation (NYSE: HHC) announced today the appointment of Linda Foggie to its Board of Directors, effective June 8, 2022.
  • She oversees the operations ofCiti's global portfolio of occupied real estate, which spans across over 90 countries.
  • "Linda's foundation in architecture and design and her role as an advocate for sustainability practices and technology innovations make her an ideal addition to our board," said William Ackman, Chairman of the Board of The Howard Hughes Corporation.
  • The Howard Hughes Corporation is traded on the New York Stock Exchange as HHC.

Immune Therapeutics, Inc. Announces Expansion of its Board of Directors

Retrieved on: 
Friday, June 3, 2022

Dr. Wilson is a trained immunologist with more than 25 years of experience in biomedical research and executive management.

Key Points: 
  • Dr. Wilson is a trained immunologist with more than 25 years of experience in biomedical research and executive management.
  • He is the Chief Innovation Officer of Statera Biopharma, Inc. and an Associate Clinical Professor at the University of California, San Diego.
  • Dr. Selsky is board certified in Pediatrics, Pediatric hematology and oncology and Palliative medicine.
  • Kevin Phelps, CEO commented; We are pleased to welcome our new members to the Board.

TEAM WIND FORCE RIDES AGAIN TO RAISE FUNDS FOR NATIONAL MULTIPLE SCLEROSIS SOCIETY

Retrieved on: 
Wednesday, May 11, 2022

DALLAS, May 11, 2022 /PRNewswire/ -- Team Wind Force, a cycling team of 13 renewable energy industry professionals organized by Tri Global Energy, is gearing up to take part in the 35th anniversary year of the Bike MS fundraiser, benefitting the National Multiple Sclerosis Society.

Key Points: 
  • DALLAS, May 11, 2022 /PRNewswire/ -- Team Wind Force, a cycling team of 13 renewable energy industry professionals organized by Tri Global Energy, is gearing up to take part in the 35th anniversary year of the Bike MS fundraiser, benefitting the National Multiple Sclerosis Society.
  • For their sixth year of participation, Team Wind Force has set an ambitious fundraising goal of $40,000.
  • Tri Global Energy is one of America's top developers of renewable energy, specifically wind and solar power.
  • It is estimated that almost one million Americans live with multiple sclerosis (MS), an unpredictable, often disabling disease of the central nervous system.